Aromasin (Exemestane) - 30 tb/25 mg - exp. 2030

★★★★★5.0 · 3 reviews

Exemestane is a steroidal Aromatase Inhibitor (AI) that is most commonly known as Aromasin. In fact, the Aromasin brand name is the only pharmaceutical grade brand of the Exemestane AI due to the tight patent Upjohn has maintained on the product. While tightly controlled by the pharmaceutical giant, Aromasin is available in numerous countries around the globe. Dosage: In a performance setting, standard Aromasin doses will normally be 12.5-25mg every other day. Most should be fine with 12.5mg every other day, with some getting by with only two to three doses per week. The individuals total sensitivity and the composition of the steroid in cycle in question will dictate the final outcome. There will be, however, some who require a daily dose with as much as 25mg per day. This should be short lived and only continued as long as necessary due to the possible cholesterol issues. This type of use can prove very useful for the competitive bodybuilder 7-14 days leading up to the completion in an effort to come in as dry and hard as possible. But again, this full dose use is only used for a limited time. How to use: Aromasin is officially classified as a steroidal suicide Aromatase Inhibitor, and carries the ability to inhibit the aromatase enzyme, which is responsible for the production or conversion of testosterone to estrogen. Aromasin has the ability to block aromatization, which in turn inhibits the production of estrogen, and thereby lowers the bodys serum estrogen levels. This will prove useful to breast cancer patients as breast cancer often feeds off the estrogen hormone. It will also prove useful to the anabolic steroid user. Then we have Aromasin as an anti-estrogen for the anabolic steroid user. By understanding its functions and traits you should already understand the effects of Aromasin in this regard. Excess estrogen levels can promote gynecomastia and water retention and possibly high blood pressure as a secondary issue. However, keep in